A Powerful Demonstration: MTM May Be Counterpoint To Pricing Complaints
This article was originally published in RPM Report
A proposed “enhanced” model for Medication Therapy Management in Medicare Part D draws rave reviews from a House subcommittee. The prospect of using medication better to lower overall costs is a great counterpoint to headlines about excessive drug prices.
Register for our free email digests: